AbbVie Inc. Financing Cash Flow 2011-2026 | ABBV
Beta
What is financing cash flow?
Financing cash flow represents cash from or used in financing activities, including borrowing, repaying debt, issuing or repurchasing stock, and paying dividends.
What is AbbVie Inc.'s current financing cash flow?
AbbVie Inc. (ABBV) annual financing cash flow for 2025 was $-12.72B, a 144.18% decline from 2024. AbbVie Inc. financing cash flow for the quarter ending March 31, 2026 was $919.0M.
What was AbbVie Inc.'s financing cash flow in 2024?
AbbVie Inc. annual financing cash flow for 2024 was $-5.21B, a 69.74% increase from 2023.
What was AbbVie Inc.'s financing cash flow in 2023?
AbbVie Inc. annual financing cash flow for 2023 was $-17.22B, a 30.56% increase from 2022.
Financing Cash Flow History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGRN/A
FY2020
$-11.50B
→
FY2025
$-12.72B
111213141516171819202122232425
5 years selected
Financing Cash Flow History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $-12.72B | -144.2% | 10-K |
| FY2024 | $-5.21B | +69.7% | 10-K |
| FY2023 | $-17.22B | +30.6% | 10-K |
| FY2022 | $-24.80B | -30.3% | 10-K |
| FY2021 | $-19.04B | -65.5% | 10-K |
| FY2020 | $-11.50B | -161.5% | 10-K |
| FY2019 | $18.71B | +230.0% | 10-K |
| FY2018 | $-14.40B | -161.2% | 10-K |
| FY2017 | $-5.51B | -40.3% | 10-K |
| FY2016 | $-3.93B | -168.3% | 10-K |
| FY2015 | $5.75B | +274.7% | 10-K |
| FY2014 | $-3.29B | +4.3% | 10-K |
| FY2013 | $-3.44B | -278.2% | 10-K |
| FY2012 | $1.93B | +128.5% | 10-K |
| FY2011 | $-6.78B | - | 10-K |
Company: AbbVie Inc.Ticker: ABBVSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →